Axel Riedel

416 total citations
8 papers, 252 citations indexed

About

Axel Riedel is a scholar working on Cardiology and Cardiovascular Medicine, Pharmacology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Axel Riedel has authored 8 papers receiving a total of 252 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Cardiology and Cardiovascular Medicine, 2 papers in Pharmacology and 2 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Axel Riedel's work include Ethics in Clinical Research (2 papers), Biomedical Ethics and Regulation (2 papers) and Health Systems, Economic Evaluations, Quality of Life (2 papers). Axel Riedel is often cited by papers focused on Ethics in Clinical Research (2 papers), Biomedical Ethics and Regulation (2 papers) and Health Systems, Economic Evaluations, Quality of Life (2 papers). Axel Riedel collaborates with scholars based in Germany, Australia and United States. Axel Riedel's co-authors include T. Rolfe, A.R. de Castella, Paul B. Fitzgerald, John Taffe, Henry Burger, Jayashri Kulkarni, Steffen Schneider, Brian D. Guth, H. Narjes and P. Tanswell and has published in prestigious journals such as SHILAP Revista de lepidopterología, Schizophrenia Research and British Journal of Clinical Pharmacology.

In The Last Decade

Axel Riedel

8 papers receiving 234 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Axel Riedel Germany	5	113	92	70	55	53	8	252
Barbara B. Tower United States	9	148 1.3×	40 0.4×	26 0.4×	42 0.8×	82 1.5×	12	352
Jennifer Prouty United States	6	201 1.8×	18 0.2×	118 1.7×	94 1.7×	75 1.4×	8	309
Frantz Ag Japan	5	211 1.9×	42 0.5×	45 0.6×	26 0.5×	85 1.6×	8	382
P. Rinieris Greece	10	45 0.4×	90 1.0×	27 0.4×	31 0.6×	21 0.4×	19	195
Søren Vinther Larsen Denmark	9	66 0.6×	12 0.1×	49 0.7×	31 0.6×	32 0.6×	23	224
Christine E. Richards United States	6	199 1.8×	49 0.5×	12 0.2×	59 1.1×	21 0.4×	6	292
Benedetta Brundu Italy	8	116 1.0×	219 2.4×	68 1.0×	28 0.5×	72 1.4×	11	440
M. Fadalti Italy	7	47 0.4×	17 0.2×	27 0.4×	98 1.8×	50 0.9×	8	419
Eva-Maria Siegmann Germany	5	109 1.0×	32 0.3×	32 0.5×	34 0.6×	7 0.1×	13	246
E. Windhager Austria	7	50 0.4×	74 0.8×	20 0.3×	45 0.8×	6 0.1×	13	213

Countries citing papers authored by Axel Riedel

Since Specialization

Citations

This map shows the geographic impact of Axel Riedel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Axel Riedel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Axel Riedel more than expected).

Fields of papers citing papers by Axel Riedel

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Axel Riedel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Axel Riedel. The network helps show where Axel Riedel may publish in the future.

Co-authorship network of co-authors of Axel Riedel

This figure shows the co-authorship network connecting the top 25 collaborators of Axel Riedel. A scholar is included among the top collaborators of Axel Riedel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Axel Riedel. Axel Riedel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

Riedel, Axel, et al.. (2009). Evaluation of clinical trials by Ethics Committees in Germany: Experience of applicants with the review of requests for opinion of the Ethics Committees - results of a survey among members of the German Association of Research-Based Pharmaceutical Companies (VFA). SHILAP Revista de lepidopterología. 1 indexed citations

Riedel, Axel, et al.. (2009). Evaluation of clinical trials by Ethics Committees in Germany - Experience of applicants with the review of requests for opinion of the Ethics Committees - results of a survey among members of the German Association of Research-Based Pharmaceutical Companies (VFA). PubMed. 7. Doc07–Doc07. 8 indexed citations

Chastek, Benjamin, Axel Riedel, Gail Wygant, & Ole Hauch. (2009). Evaluation of hospitalization and follow-up care costs among patients hospitalized with ACS treated with a stent and clopidogrel. Current Medical Research and Opinion. 25(12). 2845–2852. 3 indexed citations

Guth, Brian D., et al.. (2004). Pharmacokinetics and pharmacodynamics of terbogrel, a combined thromboxane A₂ receptor and synthase inhibitor, in healthy subjects. British Journal of Clinical Pharmacology. 58(1). 40–51. 8 indexed citations

Riedel, Axel, A.R. de Castella, Paul B. Fitzgerald, et al.. (2002). A clinical trial of adjunctive oestrogen treatment in women with schizophrenia. Archives of Women s Mental Health. 5(3). 99–104. 54 indexed citations

Kulkarni, Jayashri, Axel Riedel, A.R. de Castella, et al.. (2001). Estrogen — a potential treatment for schizophrenia. Schizophrenia Research. 48(1). 137–144. 170 indexed citations

Riedel, Axel, et al.. (1987). Relevance of eicosanoids for biochemical regulation of cardiac rhythm disturbances.. PubMed. 46(8-9). S534–8. 4 indexed citations

Riedel, Axel, et al.. (1987). Relevance of thromboxane-prostacyclin balance for cardiac rhythm disturbances.. PubMed. 242. 185–90. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact